Seeking Alpha

FDA approves GlaxoSmithKline HIV drug

The FDA approves GlaxoSmithKline's (GSK) Tivicay (dolutegravir) for the treatment of HIV. (PR)

From other sites
Comments (2)
  • AdamDivy
    , contributor
    Comments (415) | Send Message
    Sounds like great news for GSK!
    12 Aug 2013, 05:00 PM Reply Like
  • jolacious
    , contributor
    Comments (103) | Send Message
    Its a great British company
    12 Aug 2013, 09:18 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs